KRAB Box Domain Containing 4 (KRBOX4) (AA 96-125), (C-Term) anticorps
Aperçu rapide pour KRAB Box Domain Containing 4 (KRBOX4) (AA 96-125), (C-Term) anticorps (ABIN5530478)
Antigène
Voir toutes KRAB Box Domain Containing 4 (KRBOX4) AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- AA 96-125, C-Term
-
Purification
- This antibody is purified through a protein A column, followed by peptide affinity purification.
-
Immunogène
- This ZN673 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 96-125 amino acids from the C-terminal region of human ZN673.
-
Isotype
- Ig Fraction
-
-
-
-
Indications d'application
- For WB starting dilution is: 1:1000
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 0.3 mg/mL
-
Buffer
- Supplied in PBS with 0.09 % (W/V) sodium azide.
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- 4 °C,-20 °C
-
Stockage commentaire
- Store at 4°C for three months and -20°C, stable for up to one year. As with all antibodies care should be taken to avoid repeated freeze thaw cycles. Antibodies should not be exposed to prolonged high temperatures.
-
-
- KRAB Box Domain Containing 4 (KRBOX4)
-
Autre désignation
- ZN673
-
Sujet
- ZNF673 belongs to the krueppel C2H2-type zinc-finger protein family. ZNF673 may be involved in transcriptional regulation. Defects in ZNF673 may be the cause of mental retardation X-linked type 92 (MRX92). Mental retardation is characterized by significantly sub-average general intellectual functioning associated with impairments in adaptative behavior and manifested during the developmental period. Non-syndromic mental retardation patients do not manifest other clinical signs.
-
Poids moléculaire
- 20 kDa
-
ID gène
- 55634
-
UniProt
- Q5JUW0
Antigène
-